Indian experience with cryoablation for paroxysmal and persistent atrial fibrillation.

ABSTRACT:

Background

While the safety and efficacy of cryoablation procedures have been well-established in Western populations, data regarding these outcomes in the subcontinent remain limited.

Methods

This retrospective observational study included patients with paroxysmal atrial fibrillation (PAF) or persistent atrial fibrillation (PsAF) treated with cryoballoon catheter ablation according to standard clinical practice. The primary efficacy endpoints (mean follow-up of 15.3 months) were freedom from AF/atrial flutter (AFL)/atrial tachycardia (AT) lasting ≥30 s. The primary safety endpoint was the occurrence of serious procedure-related adverse events within 30 days of the procedure.

Results

The study population included 66 consecutive patients with recurrent symptomatic atri

SUBMITTER: Mondal S 

PROVIDER: S-EPMC12861925 | biostudies-literature | 2025 Nov-Dec

REPOSITORIES: biostudies-literature